Pictet-Biotech I dy GBP
Category Sector Equity Biotechnology
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price
£710.13
£-5.78 (-0.81%)
Fund Code
PIBTI
B554RF5
LU0448836352
Prices updated as at 19 May 2025
|
Prices in GBP
Investment objective
To increase the value of your investment while seeking to achieve a positive social impact. The Fund applies a sustainable strategy and invests at least two-thirds of its net assets in equities or similar securities issued by biopharmaceutical companies throughout the world. Companies supporting the health of people with high innovation capacity. Better therapies can deliver true value to patients and healthcare systems alike. These companies are tackling high unmet medical needs and reduce the pressures on healthcare budgets through the reduction of hospital admissions or symptom management. The Fund invests mainly in companies whose significant proportion of their activities are related to, but not limited to, new mechanisms of actions offering potential cures or management of diseases that were hard to treat before, technology platforms, research tools and services in the biotechnology value chain as well as the improvement of therapies or drugs.
Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
Portfolio as of 30/04/2025
Asset allocation
Show long & short position
Geographical breakdown
Continent or country allocation (%)
Market classification (%)
Stock style
Small growth
35.42%
% Weight
Value
Core
Growth
Large
9
0
5
Medium
7
4
9
Small
6
24
35
Valuation
Pictet-Biotech I dy GBP
Sector Equity Biotechnology
18.82
6.54
3.47
18.76
Growth rate
Pictet-Biotech I dy GBP
Sector Equity Biotechnology
6.45%
0.28%
-11.15%
Top 10 holdings
Security name | Sector | Country | % of assets | |
---|---|---|---|---|
1 | argenx SE ADR | - | China | 5.09 |
2 | Insmed Inc | - | United States | 4.59 |
3 | Amgen Inc | - | United States | 4.36 |
4 | Gilead Sciences Inc | - | United States | 3.65 |
5 | Regeneron Pharmaceuticals Inc | - | United States | 3.58 |
6 | TG Therapeutics Inc | - | United States | 3.50 |
7 | Alnylam Pharmaceuticals Inc | - | United States | 3.16 |
8 | BridgeBio Pharma Inc | - | United States | 3.05 |
9 | Soleno Therapeutics Inc | - | United States | 2.78 |
10 | Madrigal Pharmaceuticals Inc | - | United States | 2.70 |
Assets in top 10 holdings %
36.46%
Total no. of equity holdings
59.00
Total no. of bond holdings
-
Stock sectors
Pictet-Biotech I dy GBP
Sector Equity Biotechnology
0.00%
Basic materials
Con cyclical
Financial svs
Real estate
0.00%
Comm services
Energy
Industrials
Technology
100.00%
Con defensive
Healthcare
Utilities